definiens: shall mean : ( a ) cancer vaccines ( whether used prophylactically or therapeutically),the manufacture, sale, import, administration, activation or other use of which is covered by a claim of any PatentRights or by Technology, which Patent Rights or Technology are Controlled by Bellicum or its Affiliate ( including, without limitation Patent Rights licensed or assigned to Bellicum that cover any of the [ … * * * … ] -ARIAD MTATechnologies ), either ( x ) containing both ( but not limited to ) ( i ) a gene for a [ … * * * … ] Antigen or other Antigen directedto any indication within the Licensed Field and ( ii ) one or more genes for Inducible Costimulatory Molecules,(y ) containing a dendritic cell transfected with both ( but not limited to ) ( i ) a gene for a [ … * * * … ] Antigen or otherAntigen directed to any indication within the Licensed Field and ( ii ) one or more genes for Inducible CostimulatoryMolecules, or ( z ) containing ( i ) a peptide or protein that is a [ … * * * … ] Antigen or other Antigen directed to anyindication within the Licensed Field or an RNA that induces the expression of a [ … * * * … ] Antigen or other Antigen * * * Confidential Treatment Requested 11directed to any indication within the Licensed Field and ( ii ) a dendritic cell transfected with one or more genes forInducible Costimulatory Molecule(s ) where in any such case ( ( x ), ( y ) or ( z ) ) the encoded Inducible CostimulatoryMolecule(s ) are activated upon dimerization using a Dimerizer ; ( b ) a gene or a cell transfected with such gene codingfor an Inducible Caspase, either alone or in combination with other adjuvant genes ( such as IL-12 or HSP ), where thegene coding for such Inducible Caspase is activated upon dimerization of a Dimerizer ; ( c ) Dimerizers for use with theproducts described in clauses ( a ) or ( b ) of this Section 1.45 ; and ( d ) any treatment regimen or process utilizing anyproducts described in clauses ( a ), ( b ) or ( c ) of this Section 1.45 ; provided, however, that in the event the LicensedField is expanded pursuant to Section 2.1.2(b ) to include any non - cancer indication, clause ( a ) of this Section 1.45shall include vaccines ( as described therein ) directed at such indication as well as cancer vaccines